Ultrasound study for ovarian masses using ORADS system
Part of Women’s health & pregnancy clinical trials.
This trial uses ultrasound to evaluate ovarian cysts or masses in women. It aims to improve diagnosis by using the ORADS system, which helps classify findings more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female between 18 and 70 years old.
- You have an ovarian cyst or mass found during a routine ultrasound.
- You are willing to provide consent for the study.
- You have not had surgery for an ovarian lesion before.
- You are not pregnant.
- The mass is not a simple functional cyst (like a follicular cyst).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special ultrasound technique to get better images of ovarian growths before surgery. The goal is to improve detection and help plan the best treatment.
This trial is testing an investigational contrast agent (FRD001) to see if it improves ultrasound images of suspicious ovarian masses. The goal is to help doctors better tell if a mass is cancerous or not.
This study checks how well a specific ultrasound-based scoring tool can tell the difference between harmless (non-cancer) and harmful (cancer) ovarian masses during pregnancy. If you have a cyst or mass that’s at least 5 cm, your scan details may be used to validate the tool.
This study uses ultrasound data to help tell the difference between benign (non-cancerous) and malignant (cancerous) solid ovarian masses. It may help improve diagnosis and treatment decisions for people with this condition.
This study looks at whether a special scoring system (O-RADS) on MRI scans can help doctors tell if an ovarian mass is cancer or not before surgery. It aims to improve diagnosis and treatment planning for young girls.
This trial is testing how well a special ultrasound model (ADNEX) can predict whether an ovarian tumor is benign or cancerous. It helps doctors make better decisions, and it’s for people with complex ovarian tumors who speak Dutch.
Hear when a new Sonography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.